MCID: THY009
MIFTS: 47

Thyroid Lymphoma malady

Categories: Blood diseases, Rare diseases, Cancer diseases, Immune diseases, Endocrine diseases

Aliases & Classifications for Thyroid Lymphoma

About this section
Sources:
11Disease Ontology, 13DISEASES, 30ICD10 via Orphanet, 44NCIt, 53Orphanet, 67UMLS
See all MalaCards sources

Summaries for Thyroid Lymphoma

About this section
Wikipedia:70 Thyroid lymphoma is a rare malignant tumor constituting 1% to 2% of all thyroid malignancies and less... more...

MalaCards based summary: Thyroid Lymphoma is related to lymphoma and thyroiditis, and has symptoms including Array, Array and Array. An important gene associated with Thyroid Lymphoma is TP53 (Tumor Protein P53), and among its related pathways are DNA Damage Induced 14-3-3Sigma Signaling and ATM Pathway. Affiliated tissues include thyroid, b cells and liver, and related mouse phenotypes are neoplasm and cellular.

Related Diseases for Thyroid Lymphoma

About this section

Diseases related to Thyroid Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 106)
idRelated DiseaseScoreTop Affiliating Genes
1lymphoma10.6
2thyroiditis10.6
3salivary gland adenoid cystic carcinoma10.4CDKN2A, TP53
4biliary papillomatosis10.4CDKN2A, TP53
5split hand split foot malformation autosomal recessive10.4CDKN2A, TP53
6adenoid squamous cell carcinoma10.4CDKN2A, TP53
7simple partial epilepsy10.4CDKN2A, TP53
8ampulla of vater squamous cell carcinoma10.4CDKN2A, TP53
9cystoisosporiasis10.4CDKN2A, TP53
10vulva fibroepithelial polyp10.4CDKN2A, TP53
11oral pharyngeal disorders10.4CDKN2A, TP53
12ureter adenocarcinoma10.4CDKN2A, TP53
13pityriasis versicolor10.4CDKN2A, TP53
14liver lymphoma10.4CDKN2A, TP53
15adenofibroma10.4CDKN2A, TP53
16herpes simplex10.4CDKN2A, TP53
17pancreatic agenesis10.4CDKN2A, TP53
18spastic ataxia 310.4CDKN2A, TP53
19bladder verrucous squamous cell carcinoma10.4CDKN2A, TP53
20esophagus verrucous carcinoma10.3CDKN2A, TP53
21pituitary carcinoma10.3CDKN2A, TP53
22x-linked congenital generalized hypertrichosis10.3CDKN2A, TP53
23early myoclonic encephalopathy10.3CDKN2A, TP53
24hypoglossal nerve neoplasm10.3CDKN2A, TP53
25preeclampsia/eclampsia 310.3CDKN2A, TP53
26sulfhemoglobinemia10.3CDKN2A, TP53
27sialolithiasis10.3CDKN2A, TP53
28mesenchymoma10.3CDKN2A, TP53
29hypersensitivity reaction type iv disease10.3CDKN2A, TP53
30oligodendroglioma10.3CDKN2A, TP53
31epithelioid trophoblastic tumor10.3CDKN2A, TP53
32anal squamous cell carcinoma10.3CDKN2A, TP53
33compartment syndrome10.3CDKN2A, TP53
34synchronous bilateral breast carcinoma10.3CDKN2A, TP53
35stroma-dominant and stroma-poor composite ganglioneuroblastoma10.3CDKN2A, TP53
36actinic keratosis10.3CDKN2A, TP53
37ductal carcinoma in situ10.3CDKN2A, TP53
38grade iii astrocytoma10.3CDKN2A, TP53
39gastrointestinal neuroendocrine tumor10.3CDKN2A, TP53
40pelvic muscle wasting10.3CDKN2A, TP53
41histidine metabolism disease10.3CDKN2A, TP53
42renal hypodysplasia10.3CDKN2A, TP53
43anus adenocarcinoma10.3CDKN2A, CDKN2B
44multiple mucosal neuroma10.3CDKN2A, CDKN2B
45stromal keratitis10.3CDKN2A, TP53
46mantle cell lymphoma10.3CDKN2A, TP53
47interleukin-7 receptor alpha deficiency10.3IL7, IL7R
48integumentary system cancer10.3CDKN2A, TP53
49asrar facharzt haque syndrome10.2CDKN2A, CDKN2B
50fallopian tube mucinous adenocarcinoma10.2CDKN2A, TP53

Graphical network of the top 20 diseases related to Thyroid Lymphoma:



Diseases related to thyroid lymphoma

Symptoms for Thyroid Lymphoma

About this section

Human phenotypes related to Thyroid Lymphoma:

 53 (show all 14)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 goiter53 Obligate (100%)
2 lymphoma53 Obligate (100%)
3 broad neck53 Very frequent (99-80%)
4 hypothyroidism53 Frequent (79-30%)
5 hashimoto thyroiditis53 Frequent (79-30%)
6 hoarse voice53 Frequent (79-30%)
7 dysphagia53 Frequent (79-30%)
8 dyspnea53 Frequent (79-30%)
9 lymphadenopathy53 Frequent (79-30%)
10 upper airway obstruction53 Frequent (79-30%)
11 stridor53 Frequent (79-30%)
12 hyperthyroidism53 Occasional (29-5%)
13 pain53 Occasional (29-5%)
14 respiratory distress53 Very rare (<4-1%)

Drugs & Therapeutics for Thyroid Lymphoma

About this section

Drugs for Thyroid Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 115)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
rituximabapprovedPhase 4, Phase 3, Phase 21654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
2
Methylprednisoloneapproved, vet_approvedPhase 4115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
MethotrexateapprovedPhase 415181959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
4
Prednisoloneapproved, vet_approvedPhase 4115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
5
Folic Acidapproved, nutraceutical, vet_approvedPhase 4427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
6Gastrointestinal AgentsPhase 4, Phase 28109
7ImmunoglobulinsPhase 4, Phase 3, Phase 26045
8Immunosuppressive AgentsPhase 4, Phase 2, Phase 112770
9AntimetabolitesPhase 4, Phase 2, Phase 3, Phase 111774
10Antimetabolites, AntineoplasticPhase 4, Phase 2, Phase 17171
11Protective AgentsPhase 4, Early Phase 17190
12Antirheumatic AgentsPhase 4, Phase 3, Phase 210627
13AntibodiesPhase 4, Phase 3, Phase 26045
14Methylprednisolone HemisuccinatePhase 41153
15Vitamin B ComplexPhase 44229
16Neuroprotective AgentsPhase 41672
17Peripheral Nervous System AgentsPhase 422776
18Prednisolone phosphatePhase 41153
19Methylprednisolone acetatePhase 41153
20AntiemeticsPhase 43888
21Prednisolone acetatePhase 41153
22Nucleic Acid Synthesis InhibitorsPhase 44855
23Prednisolone hemisuccinatePhase 41153
24Anti-Inflammatory AgentsPhase 410355
25Folic Acid AntagonistsPhase 42200
26Dermatologic AgentsPhase 45674
27glucocorticoidsPhase 44920
28Antineoplastic Agents, HormonalPhase 45407
29Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 412767
30Autonomic AgentsPhase 49774
31HormonesPhase 413979
32Hormone AntagonistsPhase 412778
33Vitamin B9NutraceuticalPhase 44279
34FolateNutraceuticalPhase 44279
35Folinic AcidNutraceuticalPhase 43150
36Anti-Infective AgentsPhase 3, Phase 2, Phase 121402
37Antiviral AgentsPhase 2, Phase 39732
38DeoxyglucosePhase 2, Phase 3120
39Fluorodeoxyglucose F18Phase 2, Phase 3392
40RadiopharmaceuticalsPhase 2, Phase 3485
41Trace ElementsPhase 3, Phase 25802
42
IodinePhase 3, Phase 2, Early Phase 15467553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
43MicronutrientsPhase 3, Phase 25802
44Anti-Infective Agents, LocalPhase 3, Phase 21785
45Antibodies, MonoclonalPhase 3, Phase 23795
46Iodine-131 anti-B1 antibodyPhase 3, Phase 252
47cadexomer iodinePhase 3, Phase 2, Early Phase 1514
48
IndinavirapprovedPhase 2110150378-17-95362440
Synonyms:
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide
(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
150378-17-9
157810-81-6
157810-81-6 (sulfate (1:1) (salt))
166746-42-5
1c6y
1hsg
1hsh
1k6c
1sdt
1sdu
1sdv
1sgu
216884-06-9
2avo
2avs
2avv
2bpx
AC-20034
AC1L1U7I
AKOS000280989
BIDD:GT0378
BIDD:PXR0141
C07051
 
C36H47N5O4
CHEBI:44032
Compound J
Crixivan
Crixivan (TM)
DB00224
IDV
Indinavir (*1:1 Sulfate salt*)
Indinavir [USAN]
Indinavir anhydrous
Indinavir sulfate
Indinavir sulphate
Indinavir, Sulfate (1:1)
L 735524
L-735 524
L-735,524
L-735524
LS-173382
MK-639
MolPort-000-883-804
N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
NCGC00159460-02
NSC697197
Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide
Propolis+Indinavir
RS-253
UNII-9MG78X43ZT
indinavir
49
Ritonavirapproved, investigationalPhase 2870155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
50
Prednisoneapproved, vet_approvedPhase 2135953-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone

Interventional clinical trials:

(show all 39)
idNameStatusNCT IDPhase
1Rituximab (RTX) Therapy in Patients With Active TAORecruitingNCT02378298Phase 4
2Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins LymphomaCompletedNCT00268983Phase 3
3Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2, Phase 3
4Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.RecruitingNCT02964858Phase 3
5External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesUnknown statusNCT00637637Phase 2
6Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 AntibodyCompletedNCT00938041Phase 2
7Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's LymphomaCompletedNCT00268203Phase 2
8A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)CompletedNCT01573000Phase 2
9Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOPCompletedNCT01868035Phase 2
10Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received RituximabCompletedNCT00996593Phase 2
11Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell LymphomaCompletedNCT00992992Phase 2
12A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...CompletedNCT00923481Phase 2
13Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's LymphomaCompletedNCT00996996Phase 2
14Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 TositumomabCompletedNCT00933335Phase 2
15Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive HistologyCompletedNCT00950755Phase 2
16Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 2
17Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantCompletedNCT00321932Phase 2
18Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)RecruitingNCT02568267Phase 2
19A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)Active, not recruitingNCT00923247Phase 1, Phase 2
20Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesCompletedNCT00215605Phase 1
21Depsipeptide to Treat Thyroid and Other Advanced CancersCompletedNCT00048334Phase 1
22Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00413075Phase 1
23Spectroscopy With Surface Coils and DecouplingCompletedNCT00581815Phase 1
24Rapamycin With Grapefruit Juice for Advanced MalignanciesCompletedNCT00375245Phase 1
25Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionRecruitingNCT01638533Phase 1
26TAA-Specific CTLS for Solid Tumors (TACTASOM)RecruitingNCT02239861Phase 1
27Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesRecruitingNCT02223052Phase 1
2811C-Acetate PET/CT Non-FDG-Avid TumorsUnknown statusNCT00687778
29Association Between Hepatitis C Virus Infection and Hematologic and Thyroid CancersCompletedNCT00342641
30A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) ExpressionCompletedNCT00718770Early Phase 1
31B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
32Vegetable Garden Feasibility Trial to Promote Function in Older Cancer SurvivorsCompletedNCT02150148
33Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph NodesRecruitingNCT01664936
34The Effect of Human Placental Explants and Pregnant Women Sera on Cancer CellsRecruitingNCT01879436
35PET Imaging of Patients With Cancer Using 124I-PU-ADRecruitingNCT02751554
3610 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used PimecrolimusRecruitingNCT00568997
37Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaRecruitingNCT02345915Early Phase 1
38Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without ChemotherapyActive, not recruitingNCT02062632
39Cardiometabolic Status in Childhood Acute Lymphoblastic LeukemiaWithdrawnNCT01688752

Search NIH Clinical Center for Thyroid Lymphoma

Genetic Tests for Thyroid Lymphoma

About this section

Anatomical Context for Thyroid Lymphoma

About this section

MalaCards organs/tissues related to Thyroid Lymphoma:

35
Thyroid, B cells, Liver, Lymph node, Brain, Lung, Colon

Animal Models for Thyroid Lymphoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Thyroid Lymphoma:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.2CDKN2A, CDKN2B, IL7R, TP53
2MP:00053848.0CCNA2, CDKN2A, CDKN2B, IL7R, PICALM, TP53
3MP:00053977.6CCNA2, CDKN2A, CDKN2B, IL7, IL7R, PICALM
4MP:00053877.5CCNA2, CDKN2A, CDKN2B, IL7, IL7R, PICALM

Publications for Thyroid Lymphoma

About this section

Articles related to Thyroid Lymphoma:

(show top 50)    (show all 182)
idTitleAuthorsYear
1
Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma. (26608372)
2016
2
Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma. (26614433)
2016
3
Complete resolution of autoimmune thyroiditis after R-CHOP in a patient with thyroid lymphoma. (26687264)
2015
4
Evaluation of primary thyroid lymphoma by ultrasonography combined with contrast-enhanced ultrasonography: A pilot study. (26960472)
2015
5
Identification of primary thyroid lymphoma with medical imaging: A case report and review of the literature. (25364417)
2014
6
Thyroid lymphoma on a background of Hashimoto's thyroiditis: PET/CT appearances. (24679651)
2014
7
Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study. (24501704)
2013
8
Is 18F-FDG PET/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis? (23816945)
2013
9
Primary mucosa-associated lymphoid tissue thyroid lymphoma: a rare thyroid neoplasm of extrathyroid origin. (22532918)
2012
10
Thyroid lymphoma: acute presentation and long-term outcome. (21835073)
2011
11
Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis. (21875367)
2011
12
Untreated primary thyroid lymphoma in an elderly woman. (21727773)
2011
13
Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study. (20587509)
2011
14
A case of anaplastic diffuse large B-cell thyroid lymphoma: unique immunophenotype and unusual clinical presentation. (21178391)
2010
15
Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas. (20620043)
2010
16
Thyroid lymphoma: a rare tumor requiring combined management. (19671521)
2009
17
Primary thyroid lymphoma: case series with literature review. (19650181)
2009
18
Aberrant somatic hypermutations in thyroid lymphomas. (19019431)
2009
19
FDG PET/CT for assessing therapy response in primary thyroid lymphoma. (17242576)
2007
20
HLA associations, microsatellite instability and epigenetic changes in thyroid lymphoma in Chinese. (17454594)
2007
21
Primary thyroid lymphoma mimicking subacute thyroiditis. (17152291)
2006
22
Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. (16882503)
2006
23
Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. (17131397)
2006
24
Remission of a primary thyroid lymphoma after methotrexate withdrawal. (16712679)
2006
25
Ga-67 citrate and Tc-99m pertechnetate scintigraphy in thyroid lymphoma. (14688602)
2004
26
Diagnosis of thyroid lymphoma and follow-up evaluation using Ga-67 scintigraphy. (12971631)
2003
27
Comparative findings of lymphocytic thyroiditis and thyroid lymphoma. (12920749)
2003
28
Primary thyroid lymphoma is a heterogeneous disease. (11788631)
2002
29
Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? (11923138)
2002
30
Polymerase chain reaction-based clonality analysis in thyroid lymphoma. (12060861)
2002
31
Two unusual sites of colon cancer metastases and a rare thyroid lymphoma. Case 2. Chemotherapy-responsive right artial metastasis from colon carcinoma. (11481366)
2001
32
Frequent mutations of Fas gene in thyroid lymphoma. (11245438)
2001
33
DNA sequence of immunoglobulin heavy chain variable region gene in thyroid lymphoma. (11676854)
2001
34
Down's syndrome with mucosa-associated lymphoid tissue, thyroid lymphoma and cerebral infarction. (10746421)
2000
35
Hashimoto's disease and thyroid lymphoma: role of the surgeon. (10865042)
2000
36
Primary thyroid lymphoma associated with metastatic thyroid tumor: discrimination with US. (9700216)
1998
37
Acute airway obstruction due to primary thyroid lymphoma. (9102733)
1996
38
Lethal tracheal dissolution during treatment for thyroid lymphoma. (7491567)
1995
39
Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. (7730485)
1995
40
Sporadic activation of Epstein-Barr virus in thyroid lymphoma. (8574157)
1995
41
Monoclonal gammopathy as a clue to the presence of thyroid lymphoma associated with auto-immune thyroiditis. (1445050)
1992
42
Follicular colonization in thyroid lymphoma. (1632470)
1992
43
Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. (1613584)
1992
44
Primary thyroid lymphoma: MR appearance. (2061480)
1991
45
Hashimoto's thyroiditis as a risk factor of thyroid lymphoma. (2220394)
1990
46
Primary thyroid lymphoma in childhood: treatment with chemotherapy alone. (2268538)
1990
47
Hashimoto's disease, thyroid lymphoma and splenic atrophy. (2484910)
1989
48
Thyroid lymphoma. (2804581)
1989
49
Laryngeal oedema complicating thyroid lymphoma. (3199019)
1988
50
Thyroid lymphoma in a patient with hyperthyroidism. (6702880)
1984

Variations for Thyroid Lymphoma

About this section

Expression for genes affiliated with Thyroid Lymphoma

About this section
Search GEO for disease gene expression data for Thyroid Lymphoma.

Pathways for genes affiliated with Thyroid Lymphoma

About this section

Pathways related to Thyroid Lymphoma according to GeneCards Suite gene sharing:

(show all 31)
idSuper pathwaysScoreTop Affiliating Genes
19.7CCNB1, TP53
2
Show member pathways
9.7CCNB1, TP53
3
Show member pathways
9.7CCNB1, TP53
49.6CCNA2, TP53
5
Show member pathways
9.5CCNA2, CCNB1
69.5CCNA2, CCNB1
79.5CCNA2, CCNB1
8
Show member pathways
9.5CCNA2, CCNB1
9
Show member pathways
9.5CDKN2A, TP53
109.5CDKN2A, TP53
119.5CDKN2A, TP53
129.5CDKN2A, TP53
139.2CCNA2, CCNB1, TP53
149.2CCNA2, CCNB1, TP53
15
Show member pathways
9.2CCNA2, CCNB1, TP53
16
Show member pathways
9.1CCNB1, CDKN2A, TP53
179.1CCNA2, CDKN2B, TP53
189.0CDKN2A, CDKN2B, TP53
199.0CDKN2A, CDKN2B, TP53
20
Show member pathways
9.0CCNA2, CDKN2A, TP53
218.9IL7, IL7R, TP53
22
Show member pathways
8.8CCNA2, CDKN2A, CDKN2B
23
Show member pathways
8.7CCNB1, CDKN2B, IL7R
248.6CCNA2, CCNB1, CDKN2A, TP53
25
Show member pathways
8.6CCNA2, CCNB1, CDKN2A, TP53
26
Show member pathways
8.5CCNA2, CDKN2A, CDKN2B, TP53
278.5CCNA2, CDKN2A, CDKN2B, TP53
28
Show member pathways
8.1CCNA2, CCNB1, CDKN2A, CDKN2B, TP53
29
Show member pathways
8.1CCNA2, CCNB1, CDKN2A, CDKN2B, TP53
30
Show member pathways
8.1CCNA2, CCNB1, CDKN2A, CDKN2B, TP53
31
Show member pathways
8.1CCNA2, CCNB1, CDKN2A, CDKN2B, TP53

GO Terms for genes affiliated with Thyroid Lymphoma

About this section

Biological processes related to Thyroid Lymphoma according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1replicative senescenceGO:00903999.9CDKN2A, TP53
2positive regulation of fibroblast proliferationGO:00481469.8CCNA2, CCNB1
3negative regulation of phosphorylationGO:00423269.7CDKN2A, CDKN2B
4regulation of cyclin-dependent protein serine/threonine kinase activityGO:00000799.6CCNA2, CDKN2B
5protein complex assemblyGO:00064619.4CCNB1, PICALM, TP53
6cell cycle arrestGO:00070509.2CDKN2A, CDKN2B, TP53
7cellular response to hypoxiaGO:00714569.2CCNA2, CCNB1, TP53
8Ras protein signal transductionGO:00072658.7CCNA2, CDKN2A, TP53

Molecular functions related to Thyroid Lymphoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cyclin-dependent protein serine/threonine kinase inhibitor activityGO:00048619.7CDKN2A, CDKN2B
2protein kinase bindingGO:00199018.1CCNA2, CCNB1, CDKN2A, CDKN2B, TP53

Sources for Thyroid Lymphoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet